Completed
Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients
NCT01639599
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +3 more
- Locations
-
Not specified